跳至主要内容
临床试验/CTRI/2022/06/043408
CTRI/2022/06/043408招募中不适用

Randomized Controlled clinical Study on the Efficacy of Fluticasone and Bharangi(Clerodendrom serratum Linn) Arka as a Nasal Spray in Pratishyaya (Chronic Allergic Rhinitis) in Children.

DrDeepthi Balakrishnan1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2022年11月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
84
试验地点
1
主要终点
Rhinorrhea and Sneezing expected to decrease after treatment from 1st day to the 7th day

研究概览

简要总结

Autism spectrum disorder (ASD) is a complex developmental condition characterized by qualitative abnormalities in social interactions, reduced communication skills, and restricted repetitive behaviors and activities. There is no direct reference to ASD in Samhitas and it can be considered as an Anukta vyadhiUnmada, a disease that afflicts manovaha srothas,is characterized by the perversion of intellect, mind, and memory.ASD can be correlated to Vatika unmada. The treatment of unmada involves various Ayurvedic formulations. Medha gulika is a polyherbal formulation indicated in anxiety and mental depression, dementia and it improves memory, concentration, and brain functioning (medhya). Bhunaga Talia is an anubhootayoga indicated in treatment of apasmarabhootonmadavaksanga etc.Nasya and shiroshirodhara are effective in treating manovaha srothovikaras.**Bhunaga taila and Medha gulika can be combined to develop an effective treatment protocol for ASD. The main aim of this study is to develop a protocol of treatment for a patient suffering from ASD, which helps manage the symptoms and make behavioral improvement. A 5-year-old female child who was brought to the OPD with the diagnosis of ASD was treated with both these medicines and the changes before and after the treatment was noted based on the Trivandrum Autism Behavioral Checklist (TABC). Minimal improvement was noted in the behavior of the child following treatment of 90 days.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
4.00 Year(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • 1 Patients irrespective of gender, religion, and socioeconomic status.
  • 2 Patients with Pratishyaya for more than 1 week or recurrent 3-6 episodes in a year (Chronic Allergic Rhinitis).
  • 3 Parents who are ready to provide written informed consent to their children.

排除标准

  • 1 Patients with Acute Allergic Rhinitis.
  • 2 DushtaPratishyaya, RakthaPratishyaya and SannipatajaPratishyaya.
  • 3 Infectious diseases like T.B. 4 Patients suffering from Cleft Palate, DNS, and Nasal Polyps.

结局指标

主要结局

Rhinorrhea and Sneezing expected to decrease after treatment from 1st day to the 7th day

时间窗: 1st day | 7th day

次要结局

  • Kasam,Shirashoola,Aruchi,Nasal Itching and Nasal Obstruction expected to decrease after treatment from 8th to 28th(8th day)

研究者

发起方
DrDeepthi Balakrishnan
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验